{
  "image_filename": "figure_p1_det_0_003.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/figure_p1_det_0_003.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_003",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Black background containing the U.S. Department of Health & Human Services stylized eagle logo on the left and the CDC logo on the right The image only shows organizational logos and contains no information about any clinical trial or comparison between Flublok (quadrivalent) and Fluarix (quadrivalent); it does not support the claim Note: Image is clear but provides no trial details",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Black background containing the U.S. Department of Health & Human Services stylized eagle logo on the left and the CDC logo on the right",
    "evidence_found": null,
    "reasoning": "The image only shows organizational logos and contains no information about any clinical trial or comparison between Flublok (quadrivalent) and Fluarix (quadrivalent); it does not support the claim",
    "confidence_notes": "Image is clear but provides no trial details"
  }
}